Table 1

Demographic data for the study population on presentation

Values are median (range) or number.
*22 patients were negative for both HBeAg and anti-HBe at presentation.
HBeAg, hepatitis B e antigen; anti-HBe, antibody to HBeAg; ALT, alanine aminotransferase; AFP, α fetoprotein.
No of patients3063
Age at presentation (y)38 (1–85)
Sex (M:F)1985: 1078
HBeAg:anti-HBe1215: 1826*
Albumin (g/l)45 (18–58)
ALT (U/l)42 (4–6820)
Bilirubin (μmol/l)11 (1–553)
AFP (ng/ml)4 (1–4991)
Duration of follow up (months)29 (0.6–291)